# A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation

> **NCT02822508** · PHASE2,PHASE3 · COMPLETED · sponsor: **Braintree Laboratories** · enrollment: 434 (actual)

## Conditions studied

- Constipation

## Interventions

- **DRUG:** BLI801 Laxative
- **DRUG:** BLI801 Placebo

## Key facts

- **NCT ID:** NCT02822508
- **Lead sponsor:** Braintree Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 434 (ACTUAL)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02822508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02822508, "A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02822508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*